# Optimization of PK/PD Target Attainment for Meropenem in Critically Ill Patients With Sepsis

> **NCT03560557** · — · COMPLETED · sponsor: **Universitaire Ziekenhuizen KU Leuven** · enrollment: 116 (actual)

## Conditions studied

- Critical Illness
- Pharmacokinetics

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03560557
- **Lead sponsor:** Universitaire Ziekenhuizen KU Leuven
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2012-08
- **Primary completion:** 2017-10
- **Final completion:** 2017-10
- **Target enrollment:** 116 (ACTUAL)
- **Last updated:** 2021-01-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03560557

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03560557, "Optimization of PK/PD Target Attainment for Meropenem in Critically Ill Patients With Sepsis". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT03560557. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*